Vexos Partnership Announcement
Vexos Partners with Valley Associates Global Security Corporation For the Distribution of MVM Ventilators.
READ MOREVexos conclut avec Elemaster un accord de licence exclusif pour la fabrication et la distribution du vent ...
VEXOS Inc., fournisseur mondial primé de services de fabrication d'électronique (EMS), annonce aujourd'hui avoir signé avec le groupe Elemaster un accord de licence exclusif couvrant la fabrication et la distribution du ventilateur MVM (Mechanical Ventilator Milano) à destination des Amériques
READ MOREVexos Signs Exclusive License Agreement with Elemaster to Manufacture and Distribute MVM Ventilators in t ...
VEXOS Inc., an award-winning global electronics manufacturing services (EMS) provider, today announces the signing of an exclusive license agreement with Elemaster Group to manufacture and distribute the MVM (Mechanical Ventilator Milano) Ventilator for the Americas
READ MORE
MVM: il Milano ventilatore meccanico è pronto per la produzione
Il Milano Ventilatore Meccanico (MVM) potrà entrare nelle dotazioni degli ospedali dei Paesi che riconoscono certificazione di emergenza (EUA, Emergency Use Authorization)
READ MORE
Physicists put their expertise toward ventilator shortage
Physicist Cristiano Galbiati shifted focus from the search for dark matter to the shortage of ventilators for COVID-19 patients
READ MOREHow Fermilab is Helping in the Fight Against COVID-19
Researchers at Batavia-based Fermilab have switched gears from building and running delicate detectors to building a device for delicate lungs.
READ MOREFrom Particle Physics to Hospitals: The United States Food and Drug Administration Authorizes the Mechani ...
In a little more than one month it is now shifting to production and to support of patients affected severely by COVID-19
READ MORE
Particle Physicists Develop New Vent for COVID-19 Use
In a little more than one month, from March 19 to May 1, the Mechanical Ventilator Milano (MVM) has gone from conception to reality, as it is now shifting to production and to support of patients affected severely by COVID-19.
READ MORE